{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:28Z","timestamp":1761515968647,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.4158\/ep12018.cr","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T21:05:28Z","timestamp":1342040728000},"page":"e138-e143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adrenal Cortical Carcinoma With Late Pulmonary Metastases Causing Clinicical Cushing\u2019s Syndrome: Case Report With Immunohistochemical Analysis Of Steriodogenic Enzyme Production"],"prefix":"10.1016","volume":"18","author":[{"given":"Erika F.","family":"Brutsaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"William B.","family":"Inabnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1975","series-title":"Third National Cancer Survey: Incidence data, National Cancer Institute Monograph 41","author":"National Cancer Institute","key":"10.4158\/EP12018.CR_bb0010"},{"key":"10.4158\/EP12018.CR_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: Diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"key":"10.4158\/EP12018.CR_bb0020","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12018.CR_bb0025","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"10.4158\/EP12018.CR_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12022-006-0006-0","article-title":"Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma","volume":"17","author":"Sasano","year":"2006","journal-title":"Endocr Pathol"},{"key":"10.4158\/EP12018.CR_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.4158\/EP12018.CR_bb0040","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biologic features in the prognosis of adrenocortical cancer: poor outcome of cortisol secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12018.CR_bb0045","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0046-8177(95)90280-5","article-title":"Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy","volume":"26","author":"Sasano","year":"1995","journal-title":"Hum Pathol"},{"key":"10.4158\/EP12018.CR_bb0050","first-page":"23","article-title":"Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and insitu hybridization analysis of steroidogenic enzymes in eight cases","volume":"5","author":"Sasano","year":"1992","journal-title":"Mod Pathol"},{"key":"10.4158\/EP12018.CR_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.47102\/annals-acadmedsg.V34N3p271","article-title":"Development of ipsilateral adrenocortical carcinoma sixteen years after resection of an adrenal tumour causing cushing's syndrome","volume":"34","author":"Tan","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"10.4158\/EP12018.CR_bb0060","first-page":"1917","article-title":"Cortisol as a possible marker of metastatic adrenocortical carcinoma A case report with 3-year follow-up","volume":"26","author":"Schwarte","year":"2007","journal-title":"Anticancer Res"},{"key":"10.4158\/EP12018.CR_bb0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.beem.2010.10.012","article-title":"Classification of adrenal cortical tumors: Promise of the \u2018molecular\u2019 approach","volume":"24","author":"Giordano","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP12018.CR_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"EndocrRelat Cancer"},{"key":"10.4158\/EP12018.CR_bb0075","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/1097-0142(19950515)75:10<2587::AID-CNCR2820751028>3.0.CO;2-5","article-title":"Adrenocortical carcinoma: a clinical study and treatment results of 52 patients","volume":"75","author":"Kasperlik-Za\u0142uska","year":"1995","journal-title":"Cancer"},{"key":"10.4158\/EP12018.CR_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1530\/eje.1.02011","article-title":"Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma","volume":"153","author":"Barzon","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP12018.CR_bb0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1464-410X.2002.02937.x","article-title":"Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence","volume":"90","author":"Hisamatsu","year":"2002","journal-title":"BJU Int"},{"key":"10.4158\/EP12018.CR_bb0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9343(81)90384-3","article-title":"Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center","volume":"71","author":"Bertagna","year":"1981","journal-title":"Am J Med"},{"key":"10.4158\/EP12018.CR_bb0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0046-8177(93)90088-X","article-title":"Steroidogenesis in Human adrenocortical carcinoma: Biochemical activities, immunohistochemistry and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases","volume":"24","author":"Sasano","year":"1993","journal-title":"Hum Pathol"},{"key":"10.4158\/EP12018.CR_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: A clinician's update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP12018.CR_bb0105","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12018.CR_bb0110","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2009.27.5958","article-title":"Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel","volume":"28","author":"Berruti","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP12018.CR_bb0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP12018.CR_bb0120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1023\/A:1008377915129","article-title":"Streptozocin and o, p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use","volume":"11","author":"Khan","year":"2000","journal-title":"Ann Oncol"},{"key":"10.4158\/EP12018.CR_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12672-011-0090-6","article-title":"Targeted therapies for adrenocortical carcinoma: IGF and beyond","volume":"2","author":"Demeure","year":"2011","journal-title":"Horm Cancer"},{"key":"10.4158\/EP12018.CR_bb0130","unstructured":"Fassnacht M, Terzolo M, the FIRM-ACT Study Group, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012 May 2 [Epub ahead of print]"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/5376838J443NG418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:55:34Z","timestamp":1761515734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20430083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1530891X20430083"],"URL":"https:\/\/doi.org\/10.4158\/ep12018.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal Cortical Carcinoma With Late Pulmonary Metastases Causing Clinicical Cushing\u2019s Syndrome: Case Report With Immunohistochemical Analysis Of Steriodogenic Enzyme Production","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12018.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}